Tag: Bloom Syndrome

February 22, 2015 – The U.S. Food and Drug Administration authorized for marketing 23andMe’s Bloom Syndrome carrier test, a direct-to-consumer (DTC) genetic test to determine whether a healthy person has a variant in the BLM gene that could lead to their offspring inheriting the serious …

Bloom Syndrome: FDA permits marketing of first direct-to-consumer genetic carrier test Read more »